Scan to download
BTC $79,137.62 -2.31%
ETH $2,229.28 -1.89%
BNB $670.04 -1.38%
XRP $1.44 -3.23%
SOL $89.23 -2.91%
TRX $0.3519 -0.20%
DOGE $0.1125 -3.12%
ADA $0.2616 -3.31%
BCH $425.77 -2.24%
LINK $10.08 -3.26%
HYPE $43.41 -4.88%
AAVE $92.76 -5.35%
SUI $1.09 -7.78%
XLM $0.1550 -4.32%
ZEC $513.84 -5.98%
BTC $79,137.62 -2.31%
ETH $2,229.28 -1.89%
BNB $670.04 -1.38%
XRP $1.44 -3.23%
SOL $89.23 -2.91%
TRX $0.3519 -0.20%
DOGE $0.1125 -3.12%
ADA $0.2616 -3.31%
BCH $425.77 -2.24%
LINK $10.08 -3.26%
HYPE $43.41 -4.88%
AAVE $92.76 -5.35%
SUI $1.09 -7.78%
XLM $0.1550 -4.32%
ZEC $513.84 -5.98%

Data: Pioneer Pharmaceutical Biotechnology surged over 240% during trading, having previously announced plans to acquire all shares of Conflux

2025-07-02 10:58:01
Collection

ChainCatcher news, Hong Kong listed company Pioneer Pharma Biotechnology (00399) saw a significant increase in trading volume this morning, with a peak rise of nearly 240%, reaching a maximum price of 0.7 HKD, before retreating to around 0.34 HKD.

Previously, the company announced plans to acquire 100% equity of the blockchain project Conflux to expand its presence in the blockchain field, with two founding members of Conflux currently serving as its executive directors.

app_icon
ChainCatcher Building the Web3 world with innovations.